These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 9840653

  • 1. Effects of a combined antithrombin III and protein C supplementation in porcine acute endotoxic shock.
    Fourrier F, Jourdain M, Tournoys A, Gosset P, Mangalaboyi J, Chopin C.
    Shock; 1998 Nov; 10(5):364-70. PubMed ID: 9840653
    [Abstract] [Full Text] [Related]

  • 2. Effects of inter-alpha-inhibitor in experimental endotoxic shock and disseminated intravascular coagulation.
    Jourdain M, Carrette O, Tournoys A, Fourrier F, Mizon C, Mangalaboyi J, Goudemand J, Mizon J, Chopin C.
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1825-33. PubMed ID: 9412562
    [Abstract] [Full Text] [Related]

  • 3. Influence of antithrombin III on coagulation and inflammation in porcine septic shock.
    Dickneite G, Leithäuser B.
    Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1566-72. PubMed ID: 10364091
    [Abstract] [Full Text] [Related]

  • 4. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies.
    Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, Rime A, Marey A, Lestavel P.
    Chest; 1992 Mar; 101(3):816-23. PubMed ID: 1531791
    [Abstract] [Full Text] [Related]

  • 5. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation.
    Fourrier F, Chopin C, Huart JJ, Runge I, Caron C, Goudemand J.
    Chest; 1993 Sep; 104(3):882-8. PubMed ID: 8365305
    [Abstract] [Full Text] [Related]

  • 6. Effects of N omega-nitro-L-arginine methyl ester on the endotoxin-induced disseminated intravascular coagulation in porcine septic shock.
    Jourdain M, Tournoys A, Leroy X, Mangalaboyi J, Fourrier F, Goudemand J, Gosselin B, Vallet B, Chopin C.
    Crit Care Med; 1997 Mar; 25(3):452-9. PubMed ID: 9118662
    [Abstract] [Full Text] [Related]

  • 7. Single Low Dose of Human Recombinant Antithrombin (ATryn) has no Impact on Endotoxin-Induced Disseminated Intravascular Coagulation: An Experimental Randomized Open Label Controlled Study.
    Duburcq T, Durand A, Tournoys A, Gnemmi V, Bonner C, Gmyr V, Hubert T, Pattou F, Jourdain M.
    Shock; 2019 Oct; 52(4):e60-e67. PubMed ID: 30325871
    [Abstract] [Full Text] [Related]

  • 8. Synergistic effect of antithrombin III, activated protein C and heparin on the inhibition of the tissue thromboplastin-mediated coagulation.
    Hirahara K, Etoh Y, Matsuishi T, Suzuki N, Kurata M.
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):692-6. PubMed ID: 2752479
    [Abstract] [Full Text] [Related]

  • 9. The use of antithrombin III (ATIII) for disseminated intravascular coagulation (DIC) during septic shock.
    Cohendy R, Lefrant JY, de la Coussaye JE.
    Intensive Care Med; 1998 Dec; 24(12):1344. PubMed ID: 9885894
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia.
    Emerson TE, Fournel MA, Redens TB, Taylor FB.
    Am J Med; 1989 Sep 11; 87(3B):27S-33S. PubMed ID: 2679067
    [Abstract] [Full Text] [Related]

  • 11. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
    Gómez C, Páramo JA, Rocha E.
    Sangre (Barc); 1992 Feb 11; 37(1):5-10. PubMed ID: 1585238
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
    Aoki Y, Ohishi R, Takei R, Matsuzaki O, Mohri M, Saitoh K, Gomi K, Sugihara T, Kiyota T, Yamamoto S.
    Thromb Haemost; 1994 Apr 11; 71(4):452-5. PubMed ID: 8052962
    [Abstract] [Full Text] [Related]

  • 15. Effects of low molecular weight heparin, alone or combined with antithrombin III, on mortality, fibrin deposits and hemostatic parameters in endotoxin-induced disseminated intravascular coagulation in rabbits.
    Hermida J, Montes R, Muñoz MC, Orbe J, Páramo JA, Rocha E.
    Am J Hematol; 1999 Jan 11; 60(1):6-11. PubMed ID: 9883799
    [Abstract] [Full Text] [Related]

  • 16. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
    Mavrommatis AC, Theodoridis T, Economou M, Kotanidou A, El Ali M, Christopoulou-Kokkinou V, Zakynthinos SG.
    Intensive Care Med; 2001 Dec 11; 27(12):1853-9. PubMed ID: 11797019
    [Abstract] [Full Text] [Related]

  • 17. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
    Okajima K.
    Rinsho Byori; 1994 Jan 11; 42(1):45-55. PubMed ID: 8107283
    [Abstract] [Full Text] [Related]

  • 18. Impact of withdrawing antithrombin III administration from management of septic patients with or without disseminated intravascular coagulation.
    Kawano S, Uchino S, Endo A, Saito K, Iwai K, Kase Y, Takinami M.
    Blood Coagul Fibrinolysis; 2014 Dec 11; 25(8):795-800. PubMed ID: 24806318
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.